Immunai
Decoding immunity
- Headquarters
- New York, New York
- Employees
- 51–200
- Founded
- 2018
- Business Model
- B2B
- Website
- immunai.com
- Total Funding
- $215.0M
- Last Round
- $215.0M Series BOct 2021
- Rounds
- 1
About
Immunai maps the immune system using single-cell genomics and ML to accelerate drug discovery and immunomodulatory therapeutics.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Oct 2021
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Anduril Industries is a defense technology company with a mission to transform US and allied mili...